Lupin partners with Celnova Pharma to distribute NaMuscla in Argentina and Colombia EP News Bureau Sep 27, 2024 NaMuscla (mexiletine) to be commercialised for the treatment of non-dystrophic myotonic disorders in adults
Lupin signs distribution agreement in EU territories for orphan drug NaMuscla EP News Bureau Jun 4, 2020 Reportedly, NaMuscula is the first and only licensed product for myotonia in adults with non-dystrophic myotonic disorders
